Company Description
Accentia Biopharmaceuticals emphasizes runny noses. The company acquires and develops treatments for respiratory conditions, as well as other...
Key Accentia Financials
| Company Type | Public - NASDAQ (GM): ABPI Main Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2007 Sales (mil.) | $18.3 |
| 2007 Employees | 140 |
More Accentia Financials (7 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Accentia's competition across multiple industries
Top Accentia Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Accentia Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Francis E. O'Donnell Jr. | Network | E-mail |
| CFO and Director | Alan M. Pearce | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Accentia News
- BioWorld Today June 18, 2008 [BioWorld Today] (18 Jun 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (17 Jun 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (17 Jun 2008 22:00:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.